314 related articles for article (PubMed ID: 24939422)
1. Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behçet's disease.
Ishikawa S; Taguchi M; Muraoka T; Sakurai Y; Kanda T; Takeuchi M
Br J Ophthalmol; 2014 Nov; 98(11):1508-13. PubMed ID: 24939422
[TBL] [Abstract][Full Text] [Related]
2. Choroidal thickness in Behcet's uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes.
Kim M; Kim H; Kwon HJ; Kim SS; Koh HJ; Lee SC
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6033-9. PubMed ID: 23900605
[TBL] [Abstract][Full Text] [Related]
3. QUANTITATIVE ANALYSIS OF STRUCTURAL ALTERATIONS IN THE CHOROID OF PATIENTS WITH ACTIVE BEHÇET UVEITIS.
Onal S; Uludag G; Oray M; Mengi E; Herbort CP; Akman M; Metin MM; Koc Akbay A; Tugal-Tutkun I
Retina; 2018 Apr; 38(4):828-840. PubMed ID: 28272284
[TBL] [Abstract][Full Text] [Related]
4. Long-term Change of Subfoveal Choroidal Thickness in Behçet's Disease Patients with Posterior Uveitis.
Park UC; Cho IH; Moon SW; Yu HG
Ocul Immunol Inflamm; 2018; 26(3):397-405. PubMed ID: 28080153
[TBL] [Abstract][Full Text] [Related]
5. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
[TBL] [Abstract][Full Text] [Related]
6. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.
Hamzah F; Shinojima A; Mori R; Yuzawa M
BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855
[TBL] [Abstract][Full Text] [Related]
7. Choroidal Thickness Indicates Subclinical Ocular and Systemic Inflammation in Eyes with Behçet Disease without Active Inflammation.
Chung YR; Cho EH; Jang S; Lee SY; Lee ES; Lee K
Korean J Ophthalmol; 2018 Aug; 32(4):290-295. PubMed ID: 30091307
[TBL] [Abstract][Full Text] [Related]
8. Choroidal thickness in idiopathic subfoveal choroidal neovascularization.
Cao XS; Peng XY; You QS; Zhang YP; Jonas JB
Ophthalmologica; 2014; 231(4):221-5. PubMed ID: 24603209
[TBL] [Abstract][Full Text] [Related]
9. Enhanced depth imaging optical coherence tomography findings in Behçet disease.
Coskun E; Gurler B; Pehlivan Y; Kisacik B; Okumus S; Yayuspayı R; Ozcan E; Onat AM
Ocul Immunol Inflamm; 2013 Dec; 21(6):440-5. PubMed ID: 23895216
[TBL] [Abstract][Full Text] [Related]
10. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Ogasawara M; Spaide RF
Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289
[TBL] [Abstract][Full Text] [Related]
11. Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration.
Kang HM; Kwon HJ; Yi JH; Lee CS; Lee SC
Am J Ophthalmol; 2014 May; 157(5):1013-21. PubMed ID: 24487050
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Spectral Domain Optical Coherence Tomography (SD OCT) Findings with Laser Flare Photometry (LFP) Measurements in Behçet's Uveitis.
Işık MU; Yalcındag N
Ocul Immunol Inflamm; 2020; 28(2):194-199. PubMed ID: 30556759
[No Abstract] [Full Text] [Related]
13. Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age-related macular degeneration.
Switzer DW; Mendonça LS; Saito M; Zweifel SA; Spaide RF
Retina; 2012 Jul; 32(7):1265-71. PubMed ID: 22222760
[TBL] [Abstract][Full Text] [Related]
14. Choroidal thickness in ocular sarcoidosis during quiescent phase using enhanced depth imaging optical coherence tomography.
Güngör SG; Akkoyun I; Reyhan NH; Yeşilırmak N; Yılmaz G
Ocul Immunol Inflamm; 2014 Aug; 22(4):287-93. PubMed ID: 24912003
[TBL] [Abstract][Full Text] [Related]
15. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.
Jirarattanasopa P; Ooto S; Nakata I; Tsujikawa A; Yamashiro K; Oishi A; Yoshimura N
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3663-72. PubMed ID: 22570352
[TBL] [Abstract][Full Text] [Related]
16. Functional and morphological changes in the eyes of Behçet's patients with uveitis.
Takeuchi M; Iwasaki T; Kezuka T; Usui Y; Okunuki Y; Sakai J; Goto H
Acta Ophthalmol; 2010 Mar; 88(2):257-62. PubMed ID: 19489762
[TBL] [Abstract][Full Text] [Related]
17. Subfoveal choroidal thickness in retinal angiomatous proliferation.
Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
Retina; 2014 Jul; 34(7):1316-22. PubMed ID: 24406386
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcomes in patients with refractory uveitis associated with Behçet disease treated with infliximab.
Al Rashidi S; Al Fawaz A; Kangave D; Abu El-Asrar AM
Ocul Immunol Inflamm; 2013 Dec; 21(6):468-74. PubMed ID: 23734940
[TBL] [Abstract][Full Text] [Related]
19. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
[TBL] [Abstract][Full Text] [Related]
20. Post-remission retinal microvascular and choroidal thickness changes in eyes with Behḉet's disease posterior uveitis: an OCTA longitudinal study.
Wassef AMA; Abdelhakim MASE; Macky TA; Raafat KA; Youssef MM
Int Ophthalmol; 2021 Dec; 41(12):4163-4174. PubMed ID: 34324102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
